Showing 10,961 - 10,980 results of 11,114 for search '(( 5 ((teer decrease) OR (nn decrease)) ) OR ( 100 ((we decrease) OR (a decrease)) ))', query time: 0.45s Refine Results
  1. 10961

    Image_1_Global, regional, and national years lived with disability due to blindness and vision loss from 1990 to 2019: Findings from the Global Burden of Disease Study 2019.TIF by Shasha Li (139491)

    Published 2022
    “…Purpose<p>This study aimed to provide a comprehensive assessment of burden estimates and the secular trend of blindness and vision loss, as measured by years lived with disability (YLDs), at the global, regional, and national levels.…”
  2. 10962

    Data_Sheet_1_Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis.pdf by Sha Fu (445944)

    Published 2021
    “…The alterations in clinical and biochemical parameters before and after taking sacubitril-valsartan (generally 50–100 mg b.i.d) were investigated, and safety was also assessed. …”
  3. 10963

    Image_6_Global, regional, and national years lived with disability due to blindness and vision loss from 1990 to 2019: Findings from the Global Burden of Disease Study 2019.TIF by Shasha Li (139491)

    Published 2022
    “…Purpose<p>This study aimed to provide a comprehensive assessment of burden estimates and the secular trend of blindness and vision loss, as measured by years lived with disability (YLDs), at the global, regional, and national levels.…”
  4. 10964

    Data Sheet 1_Valve-in-valve transcatheter aortic valve replacement (TAVR) leads to lower device success compared to TAVR in native stenosis.pdf by Michael Paukovitsch (16428786)

    Published 2025
    “…</p>Methods<p>Outcomes of consecutive patients treated with ViV-TAVR (N = 100) at our tertiary heart center between 2014 and 2022 were compared to TAVR (N = 2216) in native valves.…”
  5. 10965

    Image_4_Global, regional, and national years lived with disability due to blindness and vision loss from 1990 to 2019: Findings from the Global Burden of Disease Study 2019.TIF by Shasha Li (139491)

    Published 2022
    “…Purpose<p>This study aimed to provide a comprehensive assessment of burden estimates and the secular trend of blindness and vision loss, as measured by years lived with disability (YLDs), at the global, regional, and national levels.…”
  6. 10966

    Supplementary file 1_Comparative analysis of accuracy and completeness in standardized database generation for complex multilingual lung cancer pathological reports: large language... by Hao Hang (7037264)

    Published 2025
    “…</p>Results<p>This study analyzed 1,390 structured pathology databases: 1,300 from 100 Chinese cases (generated by 10 clinicians and three LLMs) and 90 from 30 TCGA English reports. …”
  7. 10967

    Table_1_Global, regional, and national years lived with disability due to blindness and vision loss from 1990 to 2019: Findings from the Global Burden of Disease Study 2019.docx by Shasha Li (139491)

    Published 2022
    “…Purpose<p>This study aimed to provide a comprehensive assessment of burden estimates and the secular trend of blindness and vision loss, as measured by years lived with disability (YLDs), at the global, regional, and national levels.…”
  8. 10968

    Image_5_Global, regional, and national years lived with disability due to blindness and vision loss from 1990 to 2019: Findings from the Global Burden of Disease Study 2019.TIF by Shasha Li (139491)

    Published 2022
    “…Purpose<p>This study aimed to provide a comprehensive assessment of burden estimates and the secular trend of blindness and vision loss, as measured by years lived with disability (YLDs), at the global, regional, and national levels.…”
  9. 10969

    Data_Sheet_1_Genomic Surveillance of Ceftriaxone-Resistant Escherichia coli in Western New York Suggests the Extended-Spectrum β-Lactamase blaCTX-M-27 Is Emerging on Distinct Plasm... by Heba H. Mostafa (3097494)

    Published 2020
    “…Isolates were collected from both inpatients and outpatients and from urine and sterile-sites over a 2 month period in 2017 or throughout the year, respectively. …”
  10. 10970

    Predicted fitness and predicted prevalence. by Taj Azarian (659326)

    Published 2020
    “…<p><b>A</b>, Relationship between predicted fitness and observed prevalence change from pre- to post-vaccine among 31 strains, in each case summing to 100%. …”
  11. 10971

    Effects of Gas Compositions on Tuning the Kinetics of CH<sub>4</sub>/CO<sub>2</sub> Hydrates with 1,3-Dioxolane: Implication for Hydrate-Based Biogas Storage by Yuanxin Yao (4884769)

    Published 2025
    “…A key to the application of hydrate-based biogas storage (primary components as CH<sub>4</sub> and CO<sub>2</sub>) lies in elucidating the mechanism of the slow kinetics and seeking solutions to enhance the kinetics. …”
  12. 10972

    Image_1_Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with... by Jin-Kai Feng (11197404)

    Published 2022
    “…</p>Results<p>As of the data cutoff on 30 August 2021, the median follow-up time was 10.0 (3.9–28.4) months. A total of 39 eligible patients were included. …”
  13. 10973
  14. 10974

    Effects of Gas Compositions on Tuning the Kinetics of CH<sub>4</sub>/CO<sub>2</sub> Hydrates with 1,3-Dioxolane: Implication for Hydrate-Based Biogas Storage by Yuanxin Yao (4884769)

    Published 2025
    “…A key to the application of hydrate-based biogas storage (primary components as CH<sub>4</sub> and CO<sub>2</sub>) lies in elucidating the mechanism of the slow kinetics and seeking solutions to enhance the kinetics. …”
  15. 10975

    Effects of Gas Compositions on Tuning the Kinetics of CH<sub>4</sub>/CO<sub>2</sub> Hydrates with 1,3-Dioxolane: Implication for Hydrate-Based Biogas Storage by Yuanxin Yao (4884769)

    Published 2025
    “…A key to the application of hydrate-based biogas storage (primary components as CH<sub>4</sub> and CO<sub>2</sub>) lies in elucidating the mechanism of the slow kinetics and seeking solutions to enhance the kinetics. …”
  16. 10976

    Image_2_Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with... by Jin-Kai Feng (11197404)

    Published 2022
    “…</p>Results<p>As of the data cutoff on 30 August 2021, the median follow-up time was 10.0 (3.9–28.4) months. A total of 39 eligible patients were included. …”
  17. 10977

    Table_1_Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with... by Jin-Kai Feng (11197404)

    Published 2022
    “…</p>Results<p>As of the data cutoff on 30 August 2021, the median follow-up time was 10.0 (3.9–28.4) months. A total of 39 eligible patients were included. …”
  18. 10978
  19. 10979
  20. 10980

    Effects of Gas Compositions on Tuning the Kinetics of CH<sub>4</sub>/CO<sub>2</sub> Hydrates with 1,3-Dioxolane: Implication for Hydrate-Based Biogas Storage by Yuanxin Yao (4884769)

    Published 2025
    “…A key to the application of hydrate-based biogas storage (primary components as CH<sub>4</sub> and CO<sub>2</sub>) lies in elucidating the mechanism of the slow kinetics and seeking solutions to enhance the kinetics. …”